Skip to content

The Efficacy of permanent sacral nerve Stimulation upon constipation symptoms in patients with severe constipation: A Randomised Controlled trial

The Efficacy of permanent sacral nerve Stimulation upon constipation symptoms in patients with severe constipation.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12611001192976
Acronym
SNS for constipation
Enrollment
59
Registered
2011-11-17
Start date
2008-01-01
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

the trial investigates whether the symptoms of chronic constipation can be relieved using the novel therapy of sacral nerve stimulation. A pacemaker device is surgically implanted above the sacral nerve so that an electrical stimulation can be applied to either S3 or S4. This has been shown to normalise the colonic contractions in faecal incontinence. This study intends to test wether the same stimulation will have an effect on the symptoms of chronic constipation.

Interventions

Double blind crossover trail The surgical placement of a sacral nerve stimulator is a 1 hour operation under general anaesthetic performed in day surgery. A pacemaker is surgically placed in the buttock and a lead attached to the pacemaker is positioned along side S3 or S4. After surgical placement of the sacral nerve stimulator . The electrical stimulation is turned on. The patient is placed on either a subsensory stimulation or a sham stimulation for a 3 week period Setting 1- 3 weeks sham v

Double blind crossover trail The surgical placement of a sacral nerve stimulator is a 1 hour operation under general anaesthetic performed in day surgery. A pacemaker is surgically placed in the buttock and a lead attached to the pacemaker is positioned along side S3 or S4. After surgical placement of the sacral nerve stimulator . The electrical stimulation is turned on. The patient is placed on either a subsensory stimulation or a sham stimulation for a 3 week period Setting 1- 3 weeks sham v subsensory setting Device is then turned off for a 2week wash out period Wash Out (WO) 1 2weeks Setting 2- 3 weeks sham v subsensory setting WO2 2weeks Setting 3 - 3 weeks sham v suprasensory setting WO3 2weeks Setting 4 - 3 weeks sham v suprasensory setting Both supasensory and subsensory stimulation from SNS for constipation patients then enter a 2 year followup on patient preferred setting

Sponsors

Prof Ian COOK MD (SYD) FRACP
Lead SponsorIndividual

Study design

Allocation
Randomised controlled trial
Intervention model
Crossover
Primary purpose
Treatment
Masking
Blinded (masking used)

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

Patients must be Rome II positive for constipation with unsatisfactory response to standard therapies Slow transit constipation confirmed by scintigraphic or marker study free of medication which indicates constipation as a side effect Patients complete a 3week stool diary detailing bowel movements on a daily basis over a 3 week period Eligiblty is determined on the basis of less than 2 days per week a feeling of incomplete evacuation. Rome II positive according to survey 'A study of Constipation' Slow transit constipation with a % retention greater than 9% @ 72 hours Normal ano rectal manometry

Exclusion criteria

Prior abdominal surgery(ecept cholecystectomy, appendectomey, hernia repair, splenecomy, fundoplication;oophorectomy or hysterectomy) Medications which list constipation as a side effect Other medical complications non english speaker or an inability to provide informed consent inability to make fortnightly visits to St George Hospital over a 3 month period

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026